Hot News

【新股IPO】嘉和生物超額認購1246倍1手中簽率3%(附分配結果) - 香港經濟日報- 即時新聞頻道- 即市財經 @ 2020-10-06T20: Back Hot News
Keyword:嘉和生物 新股 中簽率 凍資
Concept:嘉和生物凍資
從事腫瘤及自身免疫藥物研發的嘉和生物(06998)公開招股凍資額高達3626億元,成為無收益生科新股(根據上市規則第18A章上市,俗稱B股)的「凍資王」。
嘉和生物 (新上市編號:06998)一手難求,嘉和生物一手中簽率僅3%,凍資逾3600億元,嘉和生物認購180手(90,000股)始穩獲1手。嘉和生物暗盤造好,曾高見45元,較招股價24元高87.5%,若高位沽出,一手500股最多賺10500元。分析認為,若嘉和生物股價僅升逾1成至2成,沒有「貨」的投資者可考慮買入。
從事腫瘤及自身免疫藥物研發的嘉和生物(06998)公開招股凍資額高達3626億元,成為無收益生科新股(根據上市規則第18A章上市,俗稱B股)的「凍資王」。據市場消息指出,嘉和生物合共獲得超過49萬人認購,近7萬人成為幸運兒可獲分派股份。要穩中一手,需要出資超過218萬元,認購180手(9萬股)。 ...
該股公開發售部分獲超額認購1246.52倍,凍資3626億元,成為無收益生科新股的「凍資王」。國際配售獲超購32倍,經重新分配後,香港公開發售股份占全球發售股份總數約50%。認購一手中簽率為3%,抽180手可獲一手。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.